1. Home
  2. OKYO vs HNNA Comparison

OKYO vs HNNA Comparison

Compare OKYO & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.52

Market Cap

81.3M

Sector

Health Care

ML Signal

HOLD

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

HOLD

Current Price

$9.96

Market Cap

78.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OKYO
HNNA
Founded
2007
1989
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
81.3M
78.6M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
OKYO
HNNA
Price
$1.52
$9.96
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.33
N/A
AVG Volume (30 Days)
111.1K
4.9K
Earning Date
07-18-2025
05-11-2026
Dividend Yield
N/A
5.57%
EPS Growth
N/A
38.04
EPS
N/A
0.73
Revenue
N/A
$54,590,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$13.68
Revenue Growth
N/A
3.09
52 Week Low
$1.34
$8.90
52 Week High
$3.20
$13.00

Technical Indicators

Market Signals
Indicator
OKYO
HNNA
Relative Strength Index (RSI) 45.76 50.22
Support Level $1.45 $9.67
Resistance Level $1.73 $10.32
Average True Range (ATR) 0.09 0.13
MACD -0.01 0.02
Stochastic Oscillator 17.54 58.33

Price Performance

Historical Comparison
OKYO
HNNA

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.

Share on Social Networks: